Research, Trials & Emerging Therapies
Peripheral neuropathy research is advancing rapidly across regenerative medicine, novel pain pathways, autoimmune-directed therapies, and digital tools. This page summarizes major research directions and how to find clinical trials.
Key Takeaways
- Multiple promising therapies are in clinical trials.
- ClinicalTrials.gov is the central database for finding U.S. trials.
- Some research focuses on nerve regeneration; others on pain pathways.
- Patient registries help advance research even without participating in trials.
Frequently Asked Questions
- Is there a cure for peripheral neuropathy on the horizon?
- There is no general cure, but multiple promising therapies are in clinical trials, including nerve growth factors, gene therapies for hereditary forms, novel sodium channel blockers, and disease-modifying treatments for autoimmune neuropathies. Tight glucose control remains the best disease-modifier for diabetic neuropathy.
- How do I find a clinical trial for neuropathy?
- ClinicalTrials.gov is the central U.S. registry. Search for terms such as 'peripheral neuropathy', 'diabetic neuropathy', 'small fiber neuropathy', or your specific subtype, and filter by recruiting status and location. Major academic centers often have ongoing studies and can prescreen interest.
- What treatments are being researched?
- Active research areas include sodium channel inhibitors (e.g., NaV1.7 and NaV1.8 blockers), nerve regeneration agents, immunotherapies for autoimmune neuropathies, gene therapy for hereditary neuropathies (such as hATTR), wearable neuromodulation devices, and digital pain management programs.
- Should I join a clinical trial?
- Trials offer access to new treatments and contribute to medical knowledge, but they also involve uncertainty about benefit, possible side effects, and time commitment. Discuss specific trials with your neurologist, read the informed consent carefully, and consider getting a second opinion before enrolling in any interventional study.